Search clinical trials for: healthy infants and toddlers

Total 475762 results

Société des Produits Nestlé (SPN)

Withdrawn

DHA Proof-of-Concept Study in Infants and Toddlers (DHA)

Toddlers | Infants | Nutritional Supplement
Affinivax, Inc.

Completed

A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

Healthy Volunteers | Pneumococcal Disease

United States
PATH
University College, London; FHI 360; Medical Research Council Unit, The Gambia; Serum Institute of India Pvt. Ltd...

Completed

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

Pneumonia, Pneumococcal

Gambia
Alter Farmacia, S.A.
Biopolis S.L.; Fundación Teófilo Hernando, Spain

Completed

Study of the Effects of a New Infant Formula Supplemented With a Probiotic Over the Corporal Composition of Infants

Healthy

Spain
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

Meningitis | Meningococcal Infections | Meningococcal Meningitis

Finland
Sanofi Pasteur, a Sanofi Company

Completed

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Meningitis | Meningococcal Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

Dengue | Dengue Hemorrhagic Fever

Mexico
Sanofi Pasteur, a Sanofi Company

Completed

Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers

Yellow Fever | Dengue | Dengue Hemorrhagic Fever

Peru, Colombia
Virginia Polytechnic Institute and State University
Ohio State University; University of Virginia

Completed

The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project) (The Baby CHAMP)

Cerebral Palsy | Hemiparesis

United States
GlaxoSmithKline

Completed

Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus

United States, Taiwan, Canada, Hong Kong, Turkey
Nestlé

Completed

Second Generation Human Milk Oligosaccharides Blend Study

Healthy Infants

Hungary, Poland, Bulgaria
Prothelia, Inc.
Cure CMD; The Bönnemann Laboratory, NINDS, National Institutes of Health; Oscar... and other collaborators

Completed

Retrospective Natural History Study of Infants and Toddlers With LAMA2-CMD (LAMA2 rNHS)

Merosin Deficient Congenital Muscular Dystrophy

United States
HiPP GmbH & Co. Vertrieb KG
Biofortis Mérieux NutriSciences

Terminated

The Combiotic-Study (GOLFIII)

Healthy Term Infants

France
MedImmune LLC

Completed

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Healthy

United States
Clinica Gema Leon

Completed

Craniosacral Therapy Children's, Balance-Coordination (CS-CHILDREN)

Healthy Children

Spain
Nutricia Research

Completed

Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants. (WAVE)

Healthy Term Infants

Poland
GlaxoSmithKline

Completed

Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants

Respiratory Syncytial Virus Infections

United States, Spain, Canada, Finland, Panama, South Africa, New Zealand, Australia, France
Pfizer

Terminated

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

Pneumococcal Infections

United States
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Strong Futures: A Trial of Two Primary Care Based Interventions to Promote Optimal Health in Latino Infants and Toddlers

Childhood Obesity | Health-Related Quality of Life

United States
Building Block Nutritionals, LLC
Paidion Research, Inc.

Completed

Phase II Growth and Safety Study of an Infant Formula for Healthy Term Infants

Infant Development

United States
Danone Asia Pacific Holdings Pte, Ltd.
Nutricia Research

Completed

New Infant Formula Trial in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety (Venus)

Healthy

Singapore
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
University Hospital Inselspital, Berne

Enrolling by invitation

Early Environmental and Maternal Determinants of Airway Inflammation in Wheezing Disorders in Infants

Healthy Volunteers

Switzerland
Pfizer

Completed

Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.

Meningococcal B Disease

Australia, Poland, Finland, Czechia
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants

Healthy

Finland
Federal University of Health Science of Porto Alegre

Withdrawn

Randomized Controlled Trial of Dietary Advice in Primary Care to Promote Healthy Feeding of Infants

Breast Feeding
Chang Gung Memorial Hospital

Completed

3D Craniofacial Morphologic Development of Healthy Infants

Development, Infant | Plagiocephaly | IMAGE | Craniofacial Asymmetry

Taiwan
ByHeart
Paidion Research, Inc.

Completed

Follow-up Study of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Healthy | Term Infants

United States
Abbott Nutrition

Completed

Healthy Term Infants Fed Milk-Based Infant Formula

Tolerance

United States
ByHeart
Paidion Research, Inc.

Completed

Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants

Newborn | Infants

United States
University of Lausanne Hospitals
Société des Produits Nestlé (SPN)

Completed

Monitoring of Postprandial Glycemic Variability in Healthy Young Infants (IGVM)

Glucose Intolerance | Infant Conditions

Switzerland
University of Calgary
The Sandra Schmirler Foundation: Advancing Neonatal Critical Care Fellowship...

Completed

Trends In Oxygen Saturation In Healthy Term Infants In The First Few Days Of Life: The "TOST" Study

Discharge Planning | Normative Oxygen Saturation Data Will Help us in | Describing Guidelines for Pulse Oximetry Screening | Identification of High Risk Infants

Canada
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants

Pneumococcal Infections

United States
Danone Nutricia
Nutricia Early Life Nutrition (Shanghai) Co., Ltd

Completed

To Investigate Effects of a New Infant Formula in Healthy Term Chinese Infants

Healthy Infants

China
Bharat Biotech International Limited
Indian Council of Medical Research; National Institutes of Health (NIH); Stanford... and other collaborators

Completed

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

Diarrhea

India
GlaxoSmithKline

Completed

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

Rotavirus Infection | Rotavirus Vaccines

United States
Bayer

Completed

Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)

Magnetic Resonance Imaging

United States, Canada, Germany
GlaxoSmithKline

Completed

Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants

Rotavirus

India
Butler Hospital
Brown University; Women and Infants Hospital of Rhode Island

Completed

Healthy Expectations - A Program for Pregnant Women Experiencing Depressive Symptoms (HE)

Pregnancy | Depressive Symptoms

United States
Universiteit Leiden
Wageningen University; Nutricia, Inc.; Danone Research

Completed

Baby's First Bites: Promoting Vegetable Intake in Infants and Toddlers

Childhood Obesity | Childhood Overweight | Vegetable Acceptance in Early Childhood

Netherlands
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Confirmatory Study of BK1310 in Healthy Infants

Pertussis | Tetanus | Diphtheria | Bacterial Meningitis | Poliomyelitis

Japan
University of Utah
Robert Wood Johnson Foundation

Completed

Collaborative Care for Infants at Risk (CCIR)

Child Abuse | Primary Health Care | Child Welfare

United States
Emory University
Micron Biomedical, Inc

Completed

Microneedle Patch Study in Healthy Infants/Young Children

Vaccination | Skin Absorption

United States
Bharat Biotech International Limited

Completed

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam

Rotavirus Gastroenteritis

Vietnam
Building Block Nutritionals, LLC
Paidion Research, Inc.

Completed

Growth and Safety Study of an Infant Formula for Healthy Term Infants

Infant Development

United States
Pfizer

Completed

Study To Describe The Safety, Tolerability, And Immunogenicity Of 13- Valent Pneumococcal Conjugate Vaccine Formulated In Multidose Vials When Given With Routine Pediatric Vaccines In Healthy Infants In India

Vaccines

India
GlaxoSmithKline
Novartis Vaccines

Completed

Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.

Meningococcal Disease | Infections, Meningococcal

Taiwan
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus | Rotavirus Vaccines

United States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
University Hospital, Basel, Switzerland

Completed

Estimation of Kidney Function Through Combination of Renal Biomarkers in Blood and Urine of Healthy Infants and Children. (KidMaCare)

Renal Biomarkers in Children

Switzerland
PATH

Completed

Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants

Pneumonia, Pneumococcal

Gambia

3

Subscribe